Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells

Overview of attention for article published in PLOS ONE, March 2012

Altmetric Badge

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives

Article in Vaccines (May 2022)

Анализ и перспективы применения рекомбинантного вируса вакцины, штамм MVA, в качестве вектора при разработке вакцин против заболеваний, вызванных вирусами иммунодефицита человека и обезьян

Article in Problems of Particularly Dangerous Infections (July 2019)

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned

Article in Expert Review of Vaccines (November 2018)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.